These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31903848)

  • 21. Lung Toxicity of Condensed Aerosol from E-CIG Liquids: Influence of the Flavor and the In Vitro Model Used.
    Bengalli R; Ferri E; Labra M; Mantecca P
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29053606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A framework for application of quantitative property-property relationships (QPPRs) in physiologically based pharmacokinetic (PBPK) models for high-throughput prediction of internal dose of inhaled organic chemicals.
    Chebekoue SF; Krishnan K
    Chemosphere; 2019 Jan; 215():634-646. PubMed ID: 30347358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extreme testing of undiluted e-cigarette aerosol in vitro using an Ames air-agar-interface technique.
    Thorne D; Hollings M; Seymour A; Adamson J; Dalrymple A; Ballantyne M; Gaca M
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Apr; 828():46-54. PubMed ID: 29555064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.
    McLanahan ED; El-Masri HA; Sweeney LM; Kopylev LY; Clewell HJ; Wambaugh JF; Schlosser PM
    Toxicol Sci; 2012 Mar; 126(1):5-15. PubMed ID: 22045031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicological evaluation of aerosols of a tobacco extract formulation and nicotine formulation in acute and short-term inhalation studies.
    Werley MS; Jerome AM; Oldham MJ
    Inhal Toxicol; 2014 Mar; 26(4):207-21. PubMed ID: 24568577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice-to-men comparison of inhaled drug-aerosol deposition and clearance.
    Kolanjiyil AV; Kleinstreuer C; Kleinstreuer NC; Pham W; Sadikot RT
    Respir Physiol Neurobiol; 2019 Feb; 260():82-94. PubMed ID: 30445230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery.
    Martin AR; Moore CP; Finlay WH
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1175-1188. PubMed ID: 30388902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking.
    Shao XM; Xu B; Liang J; Xie XS; Zhu Y; Feldman JL
    Nicotine Tob Res; 2013 Jul; 15(7):1248-58. PubMed ID: 23239844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane.
    Lu Y; Rieth S; Lohitnavy M; Dennison J; El-Masri H; Barton HA; Bruckner J; Yang RS
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):249-60. PubMed ID: 18226845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors.
    Frederick CB; Lomax LG; Black KA; Finch L; Scribner HE; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB
    Toxicol Appl Pharmacol; 2002 Aug; 183(1):23-40. PubMed ID: 12217639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of PBPK Modeling To Evaluate the Performance of Dissolv It, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products.
    Hassoun M; Malmlöf M; Scheibelhofer O; Kumar A; Bansal S; Selg E; Nowenwik M; Gerde P; Radivojev S; Paudel A; Arora S; Forbes B
    Mol Pharm; 2019 Mar; 16(3):1245-1254. PubMed ID: 30640475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of quantitative
    Moreau M; Simms L; Andersen ME; Trelles Sticken E; Wieczorek R; Pour SJ; Chapman F; Roewer K; Otte S; Fisher J; Stevenson M
    Front Toxicol; 2024; 6():1373325. PubMed ID: 38665213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity of aerosols of nicotine and pyruvic acid (separate and combined) in Sprague-Dawley rats in a 28-day OECD 412 inhalation study and assessment of systems toxicology.
    Phillips B; Esposito M; Verbeeck J; Boué S; Iskandar A; Vuillaume G; Leroy P; Krishnan S; Kogel U; Utan A; Schlage WK; Bera M; Veljkovic E; Hoeng J; Peitsch MC; Vanscheeuwijck P
    Inhal Toxicol; 2015; 27(9):405-31. PubMed ID: 26295358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid.
    Andersen M; Sarangapani R; Gentry R; Clewell H; Covington T; Frederick CB
    Toxicol Sci; 2000 Oct; 57(2):312-25. PubMed ID: 11006361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments.
    Bachler G; Losert S; Umehara Y; von Goetz N; Rodriguez-Lorenzo L; Petri-Fink A; Rothen-Rutishauser B; Hungerbuehler K
    Part Fibre Toxicol; 2015 Jun; 12():18. PubMed ID: 26116549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposure.
    Frederick CB; Gentry PR; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
    Inhal Toxicol; 2001 May; 13(5):359-76. PubMed ID: 11295868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Partial Differential Equation Approach to Inhalation Physiologically Based Pharmacokinetic Modeling.
    Boger E; Wigström O
    CPT Pharmacometrics Syst Pharmacol; 2018 Oct; 7(10):638-646. PubMed ID: 30084547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.